Immucell (ICCC) Cash from Investing Activities Growth (1y) (2011 - 2025)
Powered by 
Analysis
Immucell (ICCC) Cash from Investing Activities Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 24.18% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -41.51% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | -96.43% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -133.88% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 14.73% |
| Sep 30, 2025 | -569.62% |
| Jun 30, 2025 | -18.53% |
| Mar 31, 2025 | -367.69% |
| Dec 31, 2024 | -680.81% |
| Sep 30, 2024 | 83.42% |
| Jun 30, 2024 | 85.00% |
| Mar 31, 2024 | 89.69% |
| Dec 31, 2023 | 102.27% |
| Sep 30, 2023 | 27.38% |
| Jun 30, 2023 | 24.90% |
| Mar 31, 2023 | 14.36% |
| Dec 31, 2022 | -111.89% |
| Sep 30, 2022 | -9.37% |
| Jun 30, 2022 | -7.27% |
| Mar 31, 2022 | -221.29% |
| Dec 31, 2021 | -192.99% |
| Sep 30, 2021 | 54.42% |
| Jun 30, 2021 | 65.74% |
| Mar 31, 2021 | -7.96% |